Association of fear of terror with low-grade inflammation among apparently healthy employed adults

Psychosomatic Medicine

Volumn 66, Issue 4, 2004, Pages 484-491

  Melamed, Samuel ^a,b   Shirom, Arie ^b   Toker, Sharon ^b   Berliner, Shlomo ^b,c   Shapira, Itzhak ^b,c  

^a Occupational Health and Rehabilitation Institute Israel   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

C reactive protein; Depression; Inflammation; Stress; Terror

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BIOMEDICINE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROWDING; DEMOGRAPHY; DEPRESSION; EMPLOYEE; EVIDENCE BASED MEDICINE; FEAR; FEMALE; HOSPITAL; HUMAN; INFLAMMATION; ISRAEL; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; OUTCOMES RESEARCH; PERIODIC MEDICAL EXAMINATION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SAFETY; SEX DIFFERENCE; TERRORISM;

ADULT; AGED; ANXIETY DISORDERS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEPRESSIVE DISORDER; EMPLOYMENT; FEAR; FEMALE; HEALTH SURVEYS; HUMANS; INFLAMMATION; ISRAEL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PERSONNEL, HOSPITAL; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; TERRORISM;

EID: 3242745821     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000130963.52755.b9     Document Type: Article

References (69)

1. Butler AS, Panzer AM, Goldrom LR, editors. Preparing for the psychological consequences of terrorism: A public health strategy. Washington, DC: Institute of Medicine, The National Academies Press; 2003.
2. Galea S, Ahern J, Resnick H, Kilpatrick D, Bucuvalas M, Gold J, Vlahov D. Psychological sequelae of the September 11 terrorist attacks in New York City. N Engl J Med 2002;346:982-7.
3. Schuster MA, Stein BD, Jaycox LH, Collins RL, Marshall GN, Elliott MN, Zhou AJ, Kanouse DE, Morrison JL, Berry SH. A national survey of stress reactions after September 11, 2001, terrorist attacks. N Engl J Med 2001;345:1507-12.
4. Schlenger WE, Caddell JM, Ebert L, Jordan BK, Rourke KM, Wilson D, Thalji L, Dennis JM, Fairbank JA, Kulka RA. Psychological reactions to terrorist attacks: Findings from the National Study of Americans' Reactions to September 11. JAMA 2002;288:581-8.
5. Silver RC, Homan EA, McIntosh DN, Poulin M, Gil-Rivas V. Nationwide longitudinal study of psychological responses to September 11. JAMA. 2002;288:10:1235-44.
6. Bleich A, Gelkopf M, Solomon Z. Exposure to terrorism, stress-related mental health symptoms, and coping behaviors among a nationally representative sample in Israel, JAMA 2003;290:612-20.
7. Wakefield JC, Spitzer RC. Lowered estimates - but of what? Arch Gen Psychiatry 2002;59:129-30.
8. Kreitler S. Coping with panic and fear of a nonconventional threat. Clin Dermatol 2002;2:413-19.
9. Black PH. Stress and the inflammatory response: A review of neurogenic inflammation. Brain Behav Immun 2002;16:622-53.
10. Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. J Psychosom Res 2002;52:1-23.
11. Black PH. The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun 2003;17:380-64.
12. Kop WJ. The integration of cardiovascular behavioral medicine and psychoneuroimmunology: New developments based on converging research fields. Brain Behav Immun 2003;17:233-7.
13. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001;89:763-71.
14. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men, N Engl J Med 1997;336:937-9.
15. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
16. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT Research Group. Relationships of C-reactive protein and coronary heart disease in the MRFIT nested case control study. Am J Epidemiol 1996;144:537-47.
17. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn, EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Project. Arterioscler Thromb Vasc Biol 1997;17:1121-7.
18. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease), Augsburg Cohort Study, 1989-1992. Circulation 1999;94:237-42.
19. Rifai N, Ridker PM. Population distributions of C-reactive protein in apparently healthy men and women in the United States: Implication for clinical interpretation. Clin Chem 2003;49:666-9.
20. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
21. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferucci L, Harris T, Pahor M. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Bio Psychiatry 2003;54:566-72.
22. Ludwig KH, Marten-Mittag B, Lowel H, Doring A, Koenig W. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav Immun 2003;17:268-75.
23. Steptoe A, Kunz-Ebrecht SR, Owen N. Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 2003;33:667-74.
24. de Maat MP, Kluft C. Determinants of C-reactive protein concentration in blood. Ital Heart J 2001;2:189-95.
25. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002;22:1668-73.
26. Rogowsky O, Zeltser D, Shapira I, Burke M, Zakut V, Mardi T, Ben-Assayag E, Serov J, Rozenblat M, Berliner S. Gender difference in C-reactive protein concentrations in individuals with atherothrombotic risk factors and apparently healthy ones. Biomarkers. In press.
27. Steptoe A, Owen N, Kunz-Ebrecht S, Mohamed-Ali V. Inflammatory cytokines, socioeconomic status, and acute stress responsivity. Brain Behav Immun 2002;16:774-89.
28. Rohleder N, Schommer NC, Hellhammer DH, Engel R, Kirschbaum C. Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom Med 2001;63:966-72.
29. Gidron Y, Gal R, Zahavi S. Bus commuters' coping strategies and anxiety from terrorism: An example of the Israeli experience. J Trauma Stress 1999;12:185-192.
30. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999;45:2136-41.
31. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9.
32. French JRP Jr, Caplan RD, Harrison R van. The mechanisms of job stress and strain. Chichester, UK: Wiley, 1982;14-5.
33. Spitzer RL, Kroenke K, Williams JBW, and the Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIM-MD: the PHQ Primary Care Study. JAMA 1999;282:1731-44.
34. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
35. Norris FH, Friedman MJ, Watson PJ, Byrne CM, Diaz E, Kaniasty K. 60,000 disaster victims speak: part I. An empirical review of the empirical literature, 1981-2001. Psychiatry 2002;65:207-39.
36. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 2003;107:391-7.
37. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-9.
38. Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med 2003;65:347-56.
39. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
40. Libby P, Ridker PM, Maser A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
41. Rifai N, Ridker PM. Inflammatory markers and coronary heart disease. Curr Opin Lipidol 2002;13:383-9.
42. Koenig W. Inflammation and coronary heart disease: An overview. Cardiol Rev 2001;89:763-71.
43. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and the risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
44. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N, West of Scotland Coronary Prevention Study. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002;51:1596-600.
45. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
46. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-8.
47. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appelby P, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
48. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001;285:2481-5.
49. Kobayashi S, Inoue N, Ohashi Y, Terashima M, Matsui K, Mori T, Fujita H, Awano K, Kobayashi K, Azumi H, Ejiri J, Hirata K, Kawashima S, Hayashi Y, Yokozaki H, Itoh H, Yokoyama M. Interaction of oxidative stress and inflammatory response in coronary plaque instability. Important role of C-reactive protein. Arterioscler Thromb Vasc Biol 2003;23:1398-404.
50. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
51. Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, Pepys MB. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999;12:1733-9.
52. Danenberg HD, Szalai AJ, Swaminathan RV, Peng L, Chen Z, Seifert P, Fay WP, Simon DI, Edelman ER. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation 2003;108:512-5.
53. Schnorpfeil P, Noll A, Schulze R, Ehlert U, Frey K, Fischer JE. Allostatic load and work conditions. Soc Sci Med 2003;57:647-56.
54. Owen N, Poulton T, Hay FC, Mohamed-Ali V, Steptoe A. Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain Behav Immun 2003;17:286-95.
55. Kuda T, Kamada Y, Nagamine N, Oshiro J, Kuniyoshi M, Genka K, Koja K. Evaluation of inflammatory-response-induced thorascopic surgical stress. Jpn J Thorac Cardiovasc Surg 2002;50:206-9.
56. Nakamura M, Suita S, Yamanouchi T, Masumoto K, Ogita K, Taguchi S, Uesugi T. Cortisol and cytokine responses after surgery in different age groups of pediatric patients. Pediatr Surg Int 2003;19:194-9.
57. Miller RJ, Sutherland AG, Hutchison JP, Alexander DA. C-reactive protein and interleukin 6 receptor in post-traumatic stress disorder: a pilot study. Cytokine 2001;13:253-255.
58. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-137.
59. Da Silva JAP, Hall GM. The effects of gender and sex hormones on outcome in rheumatoid arthritis. Baillieres Clin Rheumatol 1992;6:196-219.
60. Lahita RG. Predisposing factors to autoimmune disease. Int J Fertil Womens Med 1997;42:115-9.
61. Wilder RL. Hormones, pregnancy and autoimmune diseases. Ann NY Acad Sci 1998;840:45-50.
62. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morage A, Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001;58:445-52.
63. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002;59:371-8.
64. Wilson CJ, Finch CE, Cohen HJ. Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 2002;50:2041-56.
65. Maier SF, Watkins LR. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood and coginition. Psych Rev 1998;105:83-107.
66. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1999.
67. Everly GS Jr. Crisis management briefings (CMB): large group crisis intervention in response to terrorism, disasters, and violence. Int J Emerg Ment Health 2000;2:53-7.
68. Stephenson J. Medical, mental health communities mobilize to cope with terror's psychological aftermath. JAMA 2001;286:1823-5.
69. Riba S, Reches H. When terror is routine: How Israeli nurses cope with multi-casualty terror. Online J Issues Nurs 2002;7:6-14.